ClinicalTrials.Veeva

Menu

The Finnish Faecal Microbiota Transplantation Study (FINFMT)

J

Joint Authority for Päijät-Häme Social and Health Care

Status

Enrolling

Conditions

Faecal Microbiota Transplantation

Study type

Observational

Funder types

Other

Identifiers

NCT03732131
HUS/3198/2017

Details and patient eligibility

About

The objective of the study is to follow up the long term effects of faecal microbiota tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in other trials meet inclusion criteria to this study. Patients will be asked for a written consent. The outcome and possible side effects of the FMT will be followed by blood and feces samples for one year and with questionaires up to ten years after the FMT.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 18 years age
  • receiving FMT for rCDI or any other madical condition
  • written consent
  • Not included in other FMT trials

Exclusion criteria

  • Unable to provide written consent
  • < 18 years age
  • Included in other FMT-trial

Trial contacts and locations

1

Loading...

Central trial contact

Perttu Lahtinen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems